Protocol for study comparing skin autofluorescence, using the AGE reader, with fasting plasma glucose and glycated hemoglobin for the detection of diabetes mellitus or impaired glucose tolerance, with the use of the short glucose tolerance test as standard.

Protocol for study comparing skin autofluorescence, using the AGE reader, with fasting plasma glucose and glycated hemoglobin for the detection of diabetes mellitus or impaired glucose tolerance, with the use of the short glucose tolerance test as standard. - Skin autofluorescence in diabetes detection

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34960

Enrollment

120

Registered

2010-09-06

Start date

2011-05-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus and impaired glucose tolerance

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: risk of diabetes

Exclusion criteria

Exclusion criteria: recent cardiovascular event or serious infection, renal insufficiency, extreme obesity (BMI >35)

Design outcomes

Primary

Measure	Time frame
sensitivity, specificity, positive and negative predicitve value SAF for diagnosis diabetes or IGT, according to ADA criteria when using GTT	—

Secondary

Measure	Time frame
comparison test criteria SAF with those of fasting or historical glucose and HbA1c levels	—

Countries

Netherlands

Outcome results